Novartis India is not traded on NSE in the last 30 days
AnnouncementsNovartis India: Outcome of AGM
AnnouncementsNovartis India fixes book closure for dividend & AGM
AnnouncementsNovartis India: Board recommends dividend
AnnouncementsNovartis India to consider dividend on May 22, 2014
Only BuyersOnly Buyers in Novartis India on BSE
AnnouncementsNovartis India : Outcome of AGM (Clause 35A)
AnnouncementsNovartis India : Outcome of AGM
AnnouncementsNovartis India AGM on July 25, 2013
100% of moneycontrol users recommend buying Novartis India.
What's your call on Novartis India today?
Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||3204.15||-0.77||3353.85||2420.00||54,587.77|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|Scheme||No. of Shares|
|IDFC Equity Opportunity - Series 1 - Direct Plan (Dividend Payout)||97,998|
|PPFAS Long Term Value Fund - Direct Plan (G)||70,085|
|Sundaram Select Micro Cap - Series I - Regular Plan (G)||40,378|
|Sundaram Select Micro Cap - Series II - Regular Plan (G)||25,841|
Kwality Recommended on Jun 25th 2014
Recommended price 45.00 | Peak from reco 58.00 28.89%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Novartis India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,270.81 crore.The company has reported a standalone sales of Rs 202.06 crore and a Net Profit of Rs 14.31 crore for the quarter ended Jun 2014.
The company management includes Christopher Snook - Chairman, Ranjit Shahani - Vice Chairman & Mng.Director, Jai Hiremath - Director, Rajendra Nath Mehrotra - Director, Manisha Girotra - Additional Director, Dinesh Charak - Addl. Director & WTD.
It is listed on the BSE with a BSE Code of 500672 and the NSE with an NSE Code of NOVARTIND.
Its Registered office is at Sandoz House, Shivsagar Estate, Dr Annie Besant Road,,Worli Mumbai,Maharashtra - 400018.
Their Registrars are Sharepro Services (India) Pvt.Ltd.